| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |